{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:11:18Z","timestamp":1778505078677,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007824","name":"American Chemistry Council","doi-asserted-by":"publisher","award":["10009468"],"award-info":[{"award-number":["10009468"]}],"id":[{"id":"10.13039\/100007824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.yrtph.2025.105950","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:11:03Z","timestamp":1758784263000},"page":"105950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessment"],"prefix":"10.1016","volume":"164","author":[{"given":"C.R.","family":"Kirman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Bus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Klaunig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Meek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2025.105950_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.crtox.2021.01.003","article-title":"Transcriptomic analyses of livers from mice exposed to 1,4-dioxane for up to 90 days to assess potential mode(s) of action underlying liver tumor development","volume":"2","author":"Chappell","year":"2021","journal-title":"Current Res. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105950_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/toxsci\/kfab030","article-title":"Identification of dose-dependent DNA damage and repair responses from subchronic exposure to 1,4-Dioxane in mice using a systems analysis approach","volume":"183","author":"Charkoftaki","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105950_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.150703","article-title":"Oxidative stress and genotoxicity in 1,4-dioxane liver toxicity as evidenced in a mouse model of glutathione deficiency","volume":"806","author":"Chen","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.yrtph.2025.105950_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.yrtph.2014.01.011","article-title":"Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment","volume":"68","author":"Dourson","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105950_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yrtph.2017.02.025","article-title":"Update: mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane","volume":"88","author":"Dourson","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105950_bib6","series-title":"ECHA Scientific Report for Evaluation of Limit Values for 1,4-dioxane at the Workplace","year":"2021"},{"key":"10.1016\/j.yrtph.2025.105950_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mrgentox.2018.07.002","article-title":"Using RNA-Seq with 11 marker genes to evaluate 1,4-dioxane compared with typical genotoxic and non-genotoxic rat hepatocarcinogens","volume":"834","author":"Furihata","year":"2018","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"10.1016\/j.yrtph.2025.105950_bib7","series-title":"1,4-dioxane in Drinking Water","year":"2018"},{"key":"10.1016\/j.yrtph.2025.105950_bib8","article-title":"1,4-Dioxane. IARC Mon0graphs supplement 7","year":"1987","journal-title":"Int. Agency Res. Cancer"},{"key":"10.1016\/j.yrtph.2025.105950_bib9","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.fct.2009.08.012","article-title":"Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years","volume":"47","author":"Kano","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105950_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/08958370802629610","article-title":"Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats 2-yr inhalation study of 1,4-dioxane in rats Tatsuya Kasai et al","volume":"21","author":"Kasai","year":"2009","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105950_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yrtph.2019.01.003","article-title":"Science peer review for the 21st century: assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias","volume":"103","author":"Kirman","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.yrtph.2025.105950_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17435390.2024.2401430","article-title":"Physiologically based pharmacokinetic modeling of metal nanoparticles for risk assessment of inhalation exposures: a state-of-the-science expert panel review","volume":"18","author":"Kirman","year":"2024","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.yrtph.2025.105950_bib13","series-title":"Continuous Exposure of Sherman Rats to Various Concentrations of 1,4-dioxane in Drinking Water for Two Years - Report 7901059 (Midland, MI)","author":"Kociba","year":"1971"},{"key":"10.1016\/j.yrtph.2025.105950_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104819","article-title":"A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane","volume":"119","author":"Lafranconi","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105950_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105428","article-title":"An integrated assessment of the 1, 4-dioxane cancer mode of action and threshold response in rodents","author":"Lafranconi","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.yrtph.2025.105950_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (Species concordance) framework: evolution of the Bradford hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105950_bib18","series-title":"Bioassay of 1,4-dioxane for Possible Carcinogenicity. CAS No. 123-91-1","year":"1978"},{"key":"10.1016\/j.yrtph.2025.105950_bib19","series-title":"Report on Carcinogens","year":"2021"},{"key":"10.1016\/j.yrtph.2025.105950_bib20","series-title":"Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum","year":"2005"},{"key":"10.1016\/j.yrtph.2025.105950_bib21","series-title":"Support of Summary Information on the Integrated Risk Information System (IRIS) (No. EPA\/635\/R-11\/003F)","article-title":"Toxicological review of 1,4-Dioxane (with inhalation update) (cas no. 123-91-1)","year":"2013"},{"key":"10.1016\/j.yrtph.2025.105950_bib22","series-title":"Office of Chemical Safety and Pollution Prevention","article-title":"Final risk evaluation for 1,4-Dioxane, CASRN: 123-91-1 (no. EPA-740-R1-8007)","year":"2020"},{"key":"10.1016\/j.yrtph.2025.105950_bib23","series-title":"The EPA Needs to Improve the Transparency of its Cancer-Assessment Process for Pesticides","year":"2022"},{"key":"10.1016\/j.yrtph.2025.105950_bib24","series-title":"Supplement to the Risk Evaluation for 1,4-Dioxane","year":"2024"},{"key":"10.1016\/j.yrtph.2025.105950_bib25","article-title":"Oxidative stress, glutathione, and CYP2E1 in 1,4-dioxane liver cytotoxicity and genotoxicity: insights from animal models","volume":"29","author":"Wang","year":"2022","journal-title":"Current Opin. Environ. Sci. Health"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:26:13Z","timestamp":1778502373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230025001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"alternative-id":["S0273230025001825"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105950","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessment","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105950"}}